Evidence map›Paper›PMID 29615517›Full record

ArticleScience signaling2018

The nociceptin receptor inhibits axonal regeneration and recovery from spinal cord injury.

Yuichi Sekine, Chad S Siegel, Tomoko Sekine-Konno, William B J Cafferty, Stephen M Strittmatter

Abstract read
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mechanisms of neurite repair.Current opinion in neurobiology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuichi SekineCellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT 06536, USA.ORCID 0000-0002-2861-603X
Chad S SiegelCellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT 06536, USA.
Tomoko Sekine-KonnoCellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT 06536, USA.
William B J CaffertyCellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT 06536, USA.ORCID 0000-0001-6263-2167
Stephen M StrittmatterCellular Neuroscience, Neurodegeneration and Repair Program, Interdepartmental Neuroscience Program, Departments of Neurology and Neuroscience, Yale University School of Medicine, New Haven, CT 06536, USA. stephen.strittmatter@yale.edu.ORCID 0000-0001-8188-3092
Yale University · US

Funding

Genome-Wide Discovery and Translational Research for Neural RepairR35NS097283 · NINDS · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2017 to 2024
$8.1M
Evaluation of Novel Targets for Retinal Ganglion Cell Axon RegenerationU01EY027256 · NEI · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2016 to 2018
$2.0M
NEI NIH HHS U01 EY027256NINDS NIH HHS R35 NS097283
6 · The paper itself

Abstract

Axonal growth after traumatic spinal cord injury is limited by endogenous inhibitors, selective blockade of which promotes partial neurological recovery. The partial repair phenotypes suggest that compensatory pathways limit improvement. Gene expression profiles of mice deficient in

Indexed as

AnimalsAxonsCell Line, TumorCells, CulturedChlorocebus aethiopsCOS CellsHEK293 CellsHumansMice, Inbred C57BLMice, KnockoutNerve RegenerationNeuronsNociceptinNociceptin ReceptorNogo Receptor 1Opioid PeptidesNociceptinNociceptin ReceptorNogo Receptor 1Opioid PeptidesReceptors, Opioid

Identifiers

PMID29615517
PMCPMC6179440
OpenAlexW2795523920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.